全文获取类型
收费全文 | 616篇 |
免费 | 24篇 |
国内免费 | 34篇 |
专业分类
儿科学 | 22篇 |
妇产科学 | 2篇 |
基础医学 | 63篇 |
口腔科学 | 8篇 |
临床医学 | 50篇 |
内科学 | 149篇 |
皮肤病学 | 7篇 |
神经病学 | 32篇 |
特种医学 | 175篇 |
外科学 | 37篇 |
综合类 | 20篇 |
预防医学 | 35篇 |
眼科学 | 12篇 |
药学 | 22篇 |
中国医学 | 1篇 |
肿瘤学 | 39篇 |
出版年
2023年 | 2篇 |
2022年 | 2篇 |
2020年 | 4篇 |
2019年 | 3篇 |
2018年 | 9篇 |
2017年 | 7篇 |
2016年 | 8篇 |
2015年 | 16篇 |
2014年 | 17篇 |
2013年 | 18篇 |
2012年 | 19篇 |
2011年 | 28篇 |
2010年 | 26篇 |
2009年 | 38篇 |
2008年 | 28篇 |
2007年 | 42篇 |
2006年 | 34篇 |
2005年 | 31篇 |
2004年 | 16篇 |
2003年 | 17篇 |
2002年 | 17篇 |
2001年 | 22篇 |
2000年 | 8篇 |
1999年 | 22篇 |
1998年 | 26篇 |
1997年 | 33篇 |
1996年 | 22篇 |
1995年 | 14篇 |
1994年 | 8篇 |
1993年 | 14篇 |
1992年 | 9篇 |
1991年 | 6篇 |
1990年 | 11篇 |
1989年 | 15篇 |
1988年 | 23篇 |
1987年 | 12篇 |
1986年 | 11篇 |
1985年 | 9篇 |
1984年 | 5篇 |
1983年 | 3篇 |
1982年 | 2篇 |
1981年 | 6篇 |
1979年 | 2篇 |
1978年 | 1篇 |
1977年 | 3篇 |
1976年 | 1篇 |
1975年 | 3篇 |
1910年 | 1篇 |
排序方式: 共有674条查询结果,搜索用时 0 毫秒
71.
72.
SG Gelsenkirchen 《MedR Medizinrecht》2007,25(9):569-571
Abstrakt 1. Eine mit der Ausübung vertrags?rztlicher T?tigkeit unvereinbare Interessen- und Pflichtenkollision liegt vor bei einer
faktischen Wahrnehmung der T?tigkeit eines Krankenhausarztes durch einen zugelassenen Arzt.
2. Ein Konsiliararzt ist ein Arzt mit einer anderen Fachgebietsbezeichnung, der in einem konkreten Behandlungsfall w?hrend
eines station?ren Aufenthalts auf seinem Fachgebiet untersucht und Behandlungsvorschl?ge macht, weil die entsprechende Fachkompetenz
in dem Krankenhaus nicht vorhanden ist. (Leits?tze des Bearbeiters) 相似文献
73.
74.
Lars H Pinborg Karen H Adams Stig Yndgaard Steen G Hasselbalch S?ren Holm Heidi Kristiansen Olaf B Paulson Gitte M Knudsen 《Journal of cerebral blood flow and metabolism》2004,24(9):1037-1045
The aim of the present study was to develop an experimental paradigm for the study of serotonergic neurotransmission in humans using positron emission tomography and the 5-HT2A selective radioligand [18F]altanserin. [18F]altanserin studies were conducted in seven subjects using the bolus/infusion approach designed for attaining steady state in blood and brain 2 hours after the initial [18F]altanserin administration. Three hours after commencement of radiotracer administration, 0.25 mg/kg of the selective serotonin reuptake inhibitor, citalopram (Lundbeck, Valby, Denmark), was administered to all subjects as a constant infusion for 20 minutes. To reduce 5-HT1A-mediated autoinhibition of cortical 5-HT release, four of the seven subjects were pretreated with the partial 5-HT1A agonist pindolol for 3 days at an increasing oral dose (25 mg on the day of scanning). In each subject, the baseline condition (120 to 180 minutes) was compared with the stimulated condition (195 to 300 minutes). Despite a pronounced increase in plasma prolactin and two subjects reporting hot flushes compatible with an 5-HT-induced adverse effect, cortical [18F]altanserin binding was insensitive to the citalopram challenge, even after pindolol pretreatment. The biochemical and cellular events possibly affecting the unsuccessful translation of the citalopram/pindolol challenge into a change in 5-HT2A receptor binding of [18F]altanserin are discussed. 相似文献
75.
76.
Rasmus Linde Steen G Hasselbalch Simon Topp Olaf B Paulson Peter L Madsen 《Journal of cerebral blood flow and metabolism》2006,26(2):170-180
In the human setting, it has been shown that acute increase in the concentration of ketone bodies by infusion of beta-hydroxybutyrate increased the cerebral blood flow (CBF) without affecting the overall cerebral metabolic activity. The mechanism by which this effect of ketone bodies was mediated is not known. Alterations in several parameters may possibly explain the increase in CBF and the resetting of the relation between CBF and cerebral metabolism. To study this phenomenon further, we measured global CBF and global cerebral metabolism with the Kety-Schmidt technique in the wakeful rat before and during infusion of ketone bodies. During acute hyperketonemia (average concentration of beta-hydroxybutyrate: 6 mmol/L), global CBF increased 65% from 108 to 178 mL/100 g min and the cerebral metabolic rates for both oxygen and glucose remained constant. This resetting of the relation between CBF and cerebral metabolism could not be explained by alterations in blood pH or arterial CO2 tension. By measuring cerebral intracellular pH by 31P nuclear magnetic resonance spectroscopy, it could further be concluded that the brain pH was unchanged during acute hyperketonemia. These observations indicate that the mechanism responsible for the increase in CBF is rather a direct effect on the cerebral endothelium than via some metabolic interactions. 相似文献
77.
78.
SG Dortmund 《MedR Medizinrecht》2003,21(1):56-59
Ohne Zusammenfassung 相似文献
79.
H Hasselbalch H S Birgens C Geisler N E Hansen 《Scandinavian journal of haematology》1985,35(3):333-338
2 patients with chronic myelogenous leukaemia developed hypercalcaemia and severe myelofibrosis in the terminal phases of their disease. Hormonal studies excluded the hypercalcaemia being caused by primary hyperparathyroidism or ectopic parathyroid hormone secretion. Its development was unrelated to the phenotype of the blast cells, as assessed by conventional cytochemistry and immunological surface typing. The finding of increased urinary cAMP excretion in 1 of the patients suggests a circulating, nonparathyroid humoral bone resorbing factor with partial biological PTH-activity to be one of the pathogenetic mechanisms responsible for the occurrence of hypercalcaemia in patients with chronic myelogenous leukaemia. 相似文献
80.
O W Bjerrum H C Hasselbalch A Drivsholm N I Nissen 《Scandinavian journal of haematology》1986,36(4):398-401
The occurrence of malignant lymphomas in 3 siblings is described. The cases include the first report of Hodgkin's disease and non-Hodgkin malignant lymphoma in dizygotic twins. Another remarkable feature was the development of malignant lymphoma, when the siblings were at the same age. Although a transmissible agent or environmental factors cannot be excluded in this family, our observations may suggest a mutual genetic predisposition in Hodgkin's disease and non-Hodgkin malignant lymphoma. 相似文献